Drug Markets/Baricitinib

Baricitinib

2 NDCs across 1 manufacturer|0 Generic,2 Brand

Baricitinib is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.

▸ More about this market

The brand product was first FDA-approved on May 31, 2018, and the first generic was approved Jul 22, 2024. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $35 million on Baricitinib across 9,553 claims for 1,609 beneficiaries.

Baricitinib is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $92.53 to $184.66 per EAa 100% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

2

0G / 2B

Manufacturers

1

competing in market

Price Spread

$92.53 – $184.66

per EA

7d Activity

11 flat

avg +0.0% WoW · of 2 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Manufacturer Breakdown

1 manufacturer producing BARICITINIB

Drug Portfolio

2 NDCs total, 2 shown

Drug Price 7d Change
OLUMIANT 4 MG TABLET
$184.6623
per EA
OLUMIANT 2 MG TABLET
$92.5328
per EA
+0.01%

Frequently Asked Questions

What is Baricitinib used to treat?

Baricitinib is used to treat rheumatoid arthritis, per the National Library of Medicine's MED-RT classification.

When did Baricitinib become available as a generic?

FDA approved the first generic Baricitinib (ANDA) on Jul 22, 2024. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.

How much does Medicare spend on Baricitinib?

In 2024, Medicare Part D spent $35 million on Baricitinib across 9,553 claims for 1,609 beneficiaries.

How many Baricitinib products are on the market?

The Baricitinib drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.

What is the price range for Baricitinib?

NADAC reference prices for Baricitinib range from $92.5328 to $184.6623 per EA — a 100% difference between cheapest and most expensive.

Which manufacturers make Baricitinib?

1 manufacturer lists Baricitinib in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (2).

How has the price of Baricitinib changed recently?

Over the past 7 days, 1 Baricitinib NDC rose and 0 fell, with a market-wide average change of +0.0%.